Table 1

Characteristics of primary MDS with GATA2 deficiency in a consecutive population-based cohort

ParameterGATA2mut (N = 28)GATA2WT (N = 398)P value
Mutations Total/distinct 28/24  
Age Median (range), years 12.3 (5.2-17.4) 10.3 (0.2-18.1) <.05 
Sex Males, N = 248 15 (54%) 233 (58%) n.s. 
 Females, N = 178 13 (46%) 165 (42%)  
Subtype RCC, N = 341 15 (54%) 326 (82%) <.01 
 RAEB/RAEB-t, N = 85 13 (46%) 72 (18%)  
Karyotype* Monosomy 7, N = 54 19 (70%) 35 (11%) <.01 
 Structural complex, N = 9 0 (0%) 9 (3%)  
 Other, N = 30 1 (4%) 29 (9%)  
 Normal, N = 253 7 (26%) 246 (77%)  
Familial disease Index patients (%) 8 (29%) 8 (2%) <.01 
ParameterGATA2mut (N = 28)GATA2WT (N = 398)P value
Mutations Total/distinct 28/24  
Age Median (range), years 12.3 (5.2-17.4) 10.3 (0.2-18.1) <.05 
Sex Males, N = 248 15 (54%) 233 (58%) n.s. 
 Females, N = 178 13 (46%) 165 (42%)  
Subtype RCC, N = 341 15 (54%) 326 (82%) <.01 
 RAEB/RAEB-t, N = 85 13 (46%) 72 (18%)  
Karyotype* Monosomy 7, N = 54 19 (70%) 35 (11%) <.01 
 Structural complex, N = 9 0 (0%) 9 (3%)  
 Other, N = 30 1 (4%) 29 (9%)  
 Normal, N = 253 7 (26%) 246 (77%)  
Familial disease Index patients (%) 8 (29%) 8 (2%) <.01 

n.s., not significant.

*

Karyotypes at diagnosis were informative in 346 of 426 patients (GATA2 mutated: n = 27; wild type: n = 319).

Includes monosomy 7 with 1 or 2 additional aberrations.

Includes 1 patient with der(1;7)(q10;p10) and trisomy 8.

Close Modal

or Create an Account

Close Modal
Close Modal